findmyKOL
Clinical trialNCT00384839CompletedPhase 2Interventional

Vidaza to Restore Hormone Thx Prostate

SponsorUS Oncology ResearchEnrollment36Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Rocky Mountain Cancer Center-Midtown

    Denver, Colorado, United States

  • Cancer Centers of Florida, P.A.

    Ocoee, Florida, United States

  • Minnesota Oncology Hematology, P.A.

    Minneapolis, Minnesota, United States

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada, United States

  • New York Oncology Hematology, P.C.

    Albany, New York, United States

  • Raleigh Hematology Oncology Associates

    Cary, North Carolina, United States

  • Northwestern Carolina Oncology Hematology

    Hickory, North Carolina, United States

  • Texas Oncology, P.A.

    Dallas, Texas, United States

  • Texas Oncology, P.A.

    Fort Worth, Texas, United States

  • Tyler Cancer Center

    Tyler, Texas, United States

  • Deke Slayton Cancer Center

    Webster, Texas, United States

  • Virginia Oncology Associates

    Norfolk, Virginia, United States

  • Cancer Care Nrothwest-South

    Spokane, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Azacitidine for injectable suspension
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2006
Primary completion
30 Nov 2009
Completion
30 Nov 2009
Last update posted
25 Oct 2018
Registered enrollment
36
Registry id
NCT00384839

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.